image

Pedro Ochoa-Allemant, MD, MSCE

I am a hepatologist, physician-scientist, and Instructor of Medicine in the Division of Gastroenterology and Hepatology at the University of Pennsylvania Perelman School of Medicine.

Born and raised in Peru, I graduated from the Universidad de San Martin de Porres and earned a Master of Science in Clinical Epidemiology (MSCE) from the University of Pennsylvania, supported by an NIH T-32 training grant. I completed my internal medicine residency at Yale School of Medicine and subsequently joined the University of Pennsylvania to complete my fellowship training in gastroenterology and advanced/transplant hepatology. 

My research centers on steatotic liver disease (SLD), particularly metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction and alcohol-associated liver disease (MetALD). I aim to advance personalized care in SLD by integrating rigorous epidemiologic methods with patient-centered and health system interventions. I am currently focused on developing point-of-care tools and risk stratification strategies to improve early identification, timely referral, and individualized management of high-risk patients with SLD.

My research is currently supported by the American Association for the Study of Liver Diseases (AASLD) through the Clinical, Translational, and Outcomes Research Award (CTORA). My work has been published in JAMA Internal Medicine, Journal of Hepatology, and Hepatology, among others.

Ellen Romich, MD, MSCE

Ellen Romich, MD, MSCE

Dr. Ellen Romich, MD, MSCE, is a rheumatologist and clinical researcher at who specializes in the care of patients with systemic autoimmune diseases. She completed her medical degree at the Cleveland Clinic Lerner College of Medicine, followed by residency and fellowship training at the Hospital of the University of Pennsylvania. Her research focuses on improving quality of life and clinical outcomes for individuals living with idiopathic inflammatory myopathies and other systemic autoimmune diseases. Through her clinical practice and research, Dr. Romich is committed to advancing evidence-based, patient-centered care for individuals with complex rheumatic diseases, with the goal of reducing disease burden and improving long-term health outcomes.

Image

Roger Kim recently published a research review that spotlighted areas for improvement regarding lung cancer screening diagnostic efficiency.

Authors

Christopher R Caruso, Roger Y Kim

Subscribe to